Genu Recurvatum Market Research Report- Global Forecast till 2023

Genu Recurvatum Market Research Report- Global Forecast till 2023

ID: MRFR/HC/3385-HCRR | | Region: Global | 85 pages | Half-Cooked Research Reports

Genu Recurvatum Market Research Report Information: Type (External, Internal, and Non-Rotatory Deformity), Diagnosis (MRI, X-Rays), Treatment (Physical Therapy, Orthoses, Bracing, Surgery), End User (Hospitals, Clinics, Labs) - Global Forecast till 2023 


Market Scenario


Genu Recurvatum is a rare orthopedic complication in which the hyperextension of the knee is greater than five degrees. It is also known as back knee or knee hyperextension. It occurs more frequently in females than it does in males, and is commonly, identified in 0.5%-1.0% of patients undergoing Total knee arthroplasty (TKA). This condition causes stress in the posterior knee structures which cause permanent damage of the joint. Genu recurvatum can also cause other conditions such as knee pain or knee osteoarthritis. Genu recurvatum can be mild, moderate, or severe. This deformity can also arise from other medical conditions such as, quadriceps weakness, bone deformities, paralysis, plantar foot flexion, and high tibial ostotomies. 


Genu recurvatum can be congenital or acquired. Congenital genu recurvatum (CGR) is an extremely rare condition, and found to be associated with other malformations such as talipes equinovarus, hip dysplasia, and absent patella. Signs and symptoms of this medical condition includes pain in the inner-leg portion of knee also known as medial tibiofemoral joint, pain in the outer back portion of knee also known as posterolateral ligamentous structures, extension of gait pattern, and difficulty in performing endurance activities. Genu recurvatum can be of three types, i.e. external rotatory deformity (ERD), internal rotatory deformity (IRD), and non-rotatory deformity (NRD). Out of three, ERD, and NRD are more severe, as ERD leads to soft tissue damage in which lower legs angle outward. Whereas, NRD, produces stress to the posterior soft tissue structures of knee. In some developing, and under developed regions, burden of orthopedics condition is rising due to lack of awareness. According to a study published in Indian Journal of Orthopaedics (IJO) in 2016, deficient orthopedic services and education such as, poor surgeon–patient ratio, poorly trained physicians to deal with musculoskeletal emergencies, and absence of minimum standard of orthopedic care, have been observed in some part of India. However, the Indian Orthopaedic Association (IOA) along with government health planners, individual medical practitioners, and medical educationists are working to find remedial solutions to these problems.


Notably, the market is expected to expand in the near future due to rise in geriatric population, high unmet needs of current treatment, and increase in research and development expenditure. Increase in aging population is the major market driver because the risk of orthopedic disorders increases exponentially with age. According to the data suggested by WHO in 2015, it is found that, worldwide, one in eight people was aged 60 years or over and by 2030, older people are projected to account for one in six people globally.


Despite these drivers, there are some issues associated with genu recurvatum market. High cost of treatment & management of genu recurvatum and related disorders, and lack of infrastructure in middle and low income countries may hamper the growth of the market.


It is estimated that genu recurvatum market is expected to grow at a CAGR 4.5% during the forecast period of 2017-2023.


Intended Audience



  • Hospitals

  • Surgical equipment Companies

  • Diagnostic clinics

  • Research and Development (R&D) Companies

  • Government Research Institute

  • Academic Institutes and Universities 


Figure: Global Genu Recurvatum Market, By Region Market Share, 2017 (%)

Genu Recurvatum Market


Sources: Annual reports, Press release, White paper, Company presentation


 


Segmentation
The Genu recurvatum market is segmented on the basis of type, diagnosis, treatment, and end-user.


On the basis of type, market is segmented into external rotatory deformity (ERD), internal rotatory deformity (IRD), and non-rotatory deformity (NRD).


On the basis of diagnosis, market is segmented into magnetic resonance imaging (MRI), X-rays, and others.


On the basis of treatment, market is classified into physical therapy, orthoses, bracing, and surgery.


On the basis of end-user, market is segmented into hospital, clinics, and others.


 


Regional Analysis
The Americas dominate the Genu recurvatum market owing to the rising awareness among people, and increasing healthcare expenditure. The Centers for Disease Control and Prevention (CDC) has stated that out of total annual healthcare expenditure, 86% is for people with chronic health conditions in the United States. Furthermore, increasing participation of bigger players and new marketers towards advancement in treatment approaches have also attracted a great deal of attention.


Europe holds the second position in the Genu recurvatum market. It is expected that the support provided by government bodies for research & development and improvement in reimbursement policies in healthcare will drive the market in Europe region.


Asia Pacific is the fastest growing Genu recurvatum market owing to the huge patient pool and developing healthcare technology.


The Middle East & Africa has the lowest market for rabies treatment market due to lack of technical knowledge and poor medical facilities. 


Key Players
Some of key the players in the market are DePuy Synthes Companies (Part of Johnson & Johnson Services, Inc.), Globus Medical, Inc., Medtronic plc, NuVasive, Inc., Smith & Nephew plc, Stryker Corporation, Zimmer Inc and others.


Research Methodology



Genu Recurvatum Market-


Sources: Annual reports, Press release, White paper, and Company presentation




Table of Contents:    

Chapter 1.    Report Prologue    

Chapter 2.    Market Introduction    


      2.1    Definition    

      2.2    Scope of the Study    

            2.2.1    Research Objective    

            2.2.2    Assumptions    

            2.2.3    Limitations    

Chapter 3.    Research Methodology

      3.1    Introduction

      3.2    Primary Research    

      3.3    Secondary research    

      3.4    Market Size Estimation

Chapter 4.    Market Dynamics

      4.1    Drivers    

      4.2    Restrains

      4.3    Opportunities    

      4.4    Challenges

      4.5    Macroeconomic Indicators

      4.6    Technology Trends & Assessment            

Chapter 5.    Market Factor Analysis

      5.1    Porters Five Forces Analysis

            5.1.1    Bargaining Power of Suppliers    

            5.1.2    Bargaining Power of Buyers

            5.1.3    Threat of New Entrants    

            5.1.4    Threat of Substitutes    

            5.1.5    Intensity of Rivalry    

      5.2    Value Chain Analysis

      5.3    Investment Feasibility Analysis    

      5.4    Pricing Analysis

Chapter 6.    Global Genu Recurvatum Market, by Type

         6.1    Introduction

      6.2    External Rotatory Deformity (ERD) 

            6.2.1    Market Estimates & Forecast, 2017 – 2023

      6.3    Internal Rotatory Deformity (IRD)

            6.3.1    Market Estimates & Forecast, 2017 – 2023

      6.4    Non-Rotatory Deformity (NRD)

            6.4.1    Market Estimates & Forecast, 2017 – 2023

Chapter 7.    Global Genu Recurvatum Market, by Diagnosis

      7.1    Introduction

      7.2    Magnetic Resonance Imaging (MRI)

            7.2.1    Market Estimates & Forecast, 2017 – 2023

      7.3    X-rays

            7.3.1    Market Estimates & Forecast, 2017 – 2023

Chapter 8.    Global Genu Recurvatum Market, by treatment

      8.1    Introduction

      8.2    Physical Therapy

            8.2.1    Market Estimates & Forecast, 2018 – 2023

      8.3    Orthoses 

            8.3.1    Market Estimates & Forecast, 2018 – 2023

      8.4    Bracing 

            8.4.1    Market Estimates & Forecast, 2018 – 2023

      8.5    Surgery 

            8.5.1    Market Estimates & Forecast, 2018 – 2023

Chapter 9.    Global Genu Recurvatum Market, by End User

      9.1    Introduction

      9.2    Hospitals

            9.2.1    Market Estimates & Forecast, 2017 – 2023

      9.3    Clinics

            9.2.2    Market Estimates & Forecast, 2017 – 2023

      9.3    Others

Chapter 10.    Global Genu Recurvatum Market, by Region

      10.1    Introduction

      10.2    Americas

            10.2.1    North America

                10.2.1.1    US

                10.2.1.1    Canada

            10.2.2    South America

      10.3    Europe

            10.3.1    Western Europe

                10.3.1.1    Germany

                10.3.1.2    France

                10.3.1.3    Italy

                10.3.1.4    Spain

                10.3.1.5    UK

                10.3.1.6    Rest of Western Europe

            10.3.2    Eastern Europe

10.4    Asia Pacific

            10.4.1    Japan

            10.4.2    China

            10.4.3    India

            10.4.4    Australia

            10.4.5    Republic of Korea

            10.4.6    Rest of Asia Pacific

      10.5    The Middle East & Africa

            10.5.1    United Arab Emirates

            10.5.2     Saudi Arabia

            10.5.3    Oman

            10.5.4    Kuwait

            10.5.5    Qatar

            10.5.6    Rest of the Middle East & Africa

Chapter 11    Company Landscape    

      11.1    Introduction    

      11.2    Market Share Analysis    

      11.3    Key Development & Strategies    

            11.3.1    Key Developments    

Chapter 12    Company Profiles    

      12.1    DePuy Synthes Companies

            12.1.1    Company Overview    

            12.1.2    Types Overview    

            12.1.3    Financials    

            12.1.4    SWOT Analysis    

      12.2    Globus Medical, Inc.    

            12.2.1    Company Overview    

            12.2.2    Types Overview    

            12.2.3    Financial Overview    

            12.2.4    Key Developments    

            12.2.5    SWOT Analysis    

      12.3    Medtronic plc

            12.3.1    Company Overview    

            12.3.2    Types Overview    

            12.3.3    Financial Overview

            12.3.4    Key Development    

            12.3.5    SWOT Analysis    

      12.4    NuVasive, Inc.

            12.4.1    Company Overview    

            12.4.2    Types/Business Segment Overview    

            12.4.3    Financial Overview    

            12.4.4    Key Development    

            12.4.5    SWOT Analysis    

12.5    Smith & Nephew plc

            12.5.1    Company Overview    

            12.5.2    Types Overview    

            12.5.3    Financial overview    

            12.5.4    Key Developments    

      12.6    Stryker Corporation    

            12.6.1    Company Overview    

            12.6.2    Types Overview    

            12.6.3    Financial Overview    

            12.6.4    Key Developments    

      12.7    Zimmer Inc

            12.7.1    Overview    

            12.7.2    Types Overview    

            12.7.3    Financials    

            12.7.4    Key Developments    

            12.7.5    SWOT Analysis    

        12.8    Others

Chapter 13    MRFR Conclusion    

      13.1    Key Findings    

            13.1.1    From CEO’s View Point    

            13.1.2    Unmet Needs of the Market    

      13.2    Key Companies to Watch    

      13.3    Prediction of Genu Recurvatum industry

Chapter 14    Appendix

LIST OF TABLES


Table 1        Genu Recurvatum Industry Synopsis, 2017 – 2023

Table 2        Genu Recurvatum Market Estimates and Forecast, 2017 – 2023, (USD Million)

Table 3        Genu Recurvatum Market by Region, 2017 – 2023, (USD Million)

Table 4        Genu Recurvatum Market by Types, 2017 – 2023, (USD Million)

Table 5        Genu Recurvatum Market by Diagnosis, 2017 – 2023, (USD Million)

Table 6        Genu Recurvatum Market by Treatment, 2017 – 2023, (USD Million)

Table 7        Genu Recurvatum Market by End Users, 2017 – 2023, (USD Million)

Table 8        North America Genu Recurvatum Market by Types, 2017 – 2023, (USD Million)

Table 9        North America Genu Recurvatum Market by Diagnosis, 2017 – 2023, (USD Million)

Table 10    North America Genu Recurvatum Market by Treatment, 2017 – 2023, (USD Million)

Table 11     North America Genu Recurvatum Market by End Users, 2017 – 2023, (USD Million)

Table 12    US Genu Recurvatum Market by Types, 2017 – 2023, (USD Million)

Table 13    US Genu Recurvatum Market by Diagnosis, 2017 – 2023, (USD Million)

Table 14    US Genu Recurvatum Market by Treatment, 2017 – 2023, (USD Million)

Table 15    US Genu Recurvatum Market by End Users, 2017 – 2023, (USD Million)

Table 16    Canada Genu Recurvatum Market by Types, 2017 – 2023, (USD Million)

Table 17    Canada Genu Recurvatum market by Diagnosis, 2017 – 2023, (USD Million)

Table 18    Canada Genu Recurvatum Market by Treatment, 2017 – 2023, (USD Million)

Table 19    Canada Genu Recurvatum market by End Users, 2017 – 2023, (USD Million)

Table 20    South America Genu Recurvatum Market by Types, 2017 – 2023, (USD Million)

Table 21    South America Genu Recurvatum Market by Diagnosis, 2017 – 2023, (USD Million)

Table 22    South America Genu Recurvatum Market by Treatment, 2017 – 2023, (USD Million)

Table 23    South America Genu Recurvatum Market by End Users, 2017 – 2023, (USD Million)

Table 24    Europe Genu Recurvatum Market by Types, 2017 – 2023, (USD Million)

Table 25    Europe Genu Recurvatum Market by Diagnosis, 2017 – 2023, (USD Million)

Table 26    Europe Genu Genu Recurvatum Market by Treatment, 2017 – 2023, (USD Million)

Table 27    Europe Genu Recurvatum Market by End Users, 2017 – 2023, (USD Million)

Table 28    Western Europe Genu Recurvatum Market by Types, 2017 – 2023, (USD Million)

Table 29    Western Europe Genu Recurvatum Market by Diagnosis, 2017 – 2023, (USD Million)

Table 30    Western Europe Genu Recurvatum Market by Treatment, 2017 – 2023, (USD Million)

Table 31    Western Europe Genu Recurvatum Market by End Users, 2017 – 2023, (USD Million)

Table 32    Eastern Europe Genu Recurvatum Market by Types, 2017 – 2023, (USD Million)

Table 33    Eastern Europe Genu Recurvatum market by Diagnosis, 2017 – 2023, (USD Million)

Table 34    Eastern Europe Genu Recurvatum Market by Treatment, 2017 – 2023, (USD Million)

Table 35    Eastern Europe Genu Recurvatum Market by End Users, 2017 – 2023, (USD Million)

Table 36    Asia Pacific Genu Recurvatum Market by Types, 2017 – 2023, (USD Million)

Table 37    Asia Pacific Genu Recurvatum Market by Diagnosis, 2017 – 2023, (USD Million)

Table 38    Asia Pacific Genu Recurvatum Market by Treatment, 2017 – 2023, (USD Million)

Table 39    Asia Pacific Genu Recurvatum market by End Users, 2017 – 2023, (USD Million)

Table 40    Middle East & Africa Genu Recurvatum Market by Types, 2017 – 2023, (USD Million)

Table 41    Middle East & Africa Genu Recurvatum Market by Diagnosis, 2017 – 2023, (USD Million)

Table 42    Middle East & Africa Genu Recurvatum Market by Treatment, 2017 – 2023, (USD Million)

Table 43    Middle East & Africa Genu Recurvatum market by End Users, 2017 – 2023, (USD Million)

 

LIST OF FIGURES

Figure 1    Research Process

Figure 2    Segmentation for Genu Recurvatum Market

Figure 3    Segmentation Market Dynamics for Genu Recurvatum Market

Figure 4    Global Genu Recurvatum market Share, by Types 2016

Figure 5    Global Genu Recurvatum market Share, by Diagnosis 2016

Figure 5    Global Genu Recurvatum market Share, by Treatment 2016

Figure 6    Global Genu Recurvatum market Share, by End Users, 2016

Figure 7    Global Genu Recurvatum market Share, by Region, 2016

Figure 8    North America Genu Recurvatum market Share, by Country, 2016

Figure 9    Europe Genu Recurvatum market Share, by Country, 2016

Figure 10    Asia Pacific Genu Recurvatum market Share, by Country, 2016

Figure 11    Middle East & Africa Genu Recurvatum market Share, by Country, 2016

Figure 12    Global Genu Recurvatum market: Company Share Analysis, 2016 (%)

Figure 13    DePuy Synthes: Key Financials

Figure 14    DePuy Synthes: Segmental Revenue

Figure 15    DePuy Synthes: Geographical Revenue

Figure 16    Globus Medical, Inc: Key Financials

Figure 17    Globus Medical, Inc.: Segmental Revenue

Figure 18    Globus Medical, Inc.: Geographical Revenue

Figure 19    Medtronic plc: Key Financials

Figure 20    Medtronic plc: Segmental Revenue

Figure 21    Medtronic plc: Geographical Revenue

Figure 22    NuVasive, Inc.: Key Financials

Figure 23    NuVasive, Inc.: Segmental Revenue

Figure 24    NuVasive, Inc.: Geographical Revenue

Figure 25    Smith & Nephew plc: Key Financials

Figure 26    Smith & Nephew plc: Segmental Revenue

Figure 27    Smith & Nephew plc: Geographical Revenue

Figure 28    Stryker Corporation: Key Financials

Figure 29    Stryker Corporation: Segmental Revenue

Figure 30    Stryker Corporation: Geographical Revenue

Figure 31    Zimmer Inc: Key Financials

Figure 32    Zimmer Inc: Segmental Revenue

Figure 33    Zimmer Inc: Geographical Revenue